Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 4, 2010, Pages

  Juncos, Julio P ^a   Grande, Joseph P ^a   Croatt, Anthony J ^a   Hebbel, Robert P ^a   Vercellotti, Gregory M ^a   Katusic, Zvonimir S ^b   Nath, Karl A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Acute kidney injury; Heme oxygenase; Inflammation; MAPK proteins; Nitric oxide synthase; Vasoocclusion

Indexed keywords

HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; KIDNEY PLASMA FLOW; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 77950855814     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00631.2009     Document Type: Article

References (54)

1. Adenbigbe A, Arije A, Akinkugbe O. Glomerular function in sickle cell disease patients during crisis. Afr J Med Sci 23: 153-160, 1994.
2. al Ani O, Baqi N. Clinical quiz. Cortical infarction secondary to intravascular sickling in the renal cortex. Pediatr Nephrol 13: 267-268, 1999.
3. 2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int 65: 1231-1239, 2004.
4. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 63: 205-211, 2000.
5. Bank N, Aynedjian HS, Qiu JH, Osei SY, Ahima RS, Fabry ME, Nagel RL. Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int 50: 184-189, 1996.
6. Bank N, Kiroycheva M, Singhal PC, Anthony GM, Southan GJ, Szabo C. Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 58: 82-89, 2000.
7. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 13: 1-7, 2004.
8. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal 12: 233-248, 2010.
9. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, Bowlin PR, Bischof JC, Hebbel RP, Vercellotti GM. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288: H2715-H2725, 2005.
10. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 53: 961-973, 2009.
11. Curtis LM, Agarwal A. HOpe for contrast-induced acute kidney injury. Kidney Int 72: 907-909, 2007.
12. de Jong PE, de Jong-Van Den Berg TW, Sewrajsingh GS, Schouten H, Donker AJ, Statius van Eps LW. The influence of indomethacin on renal haemodynamics in sickle cell anaemia. Clin Sci (Lond) 59: 245-250, 1980.
13. De Paepe ME, Trudel M. The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int 46: 1337-1345, 1994.
14. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol Renal Physiol 277: F195-F203, 1999.
15. Fabry ME, Costantini F, Pachnis A, Suzuka SM, Bank N, Aynedjian HS, Factor SM, Nagel RL. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci USA 89: 12155-12159, 1992.
16. Fabry ME, Nagel RL, Pachnis A, Suzuka SM, Costantini F. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci USA 89: 12150-12154, 1992.
17. Feltes CM, Van Eyk J, Rabb H. Distant-organ changes after acute kidney injury. Nephron Physiol 109: p80-p84, 2008.
18. Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 15: 297-307, 2008.
19. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61: 855-861, 2002.
20. Granfortuna J, Zamkoff K, Urrutia E. Acute renal infarction in sickle cell disease. Am J Hematol 23: 59-64, 1986.
21. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 96: 155-162, 1994.
22. Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 129: 288-293, 1997.
23. Juncos JP, Grande JP, Murali N, Croatt AJ, Juncos LA, Hebbel RP, Katusic ZS, Nath KA. Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol 169: 21-31, 2006.
24. Kanakiriya SK, Croatt AJ, Haggard JJ, Ingelfinger JR, Tang SS, Alam J, Nath KA. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Am J Physiol Renal Physiol 284: F546-F554, 2003.
25. Katusic ZS, d'Uscio LV, Nath KA. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci 30: 48-54, 2009.
26. Kimmelsteil P. Vascular occlusion and ischemic infarction in sickle cell disease. Am J Med Sci 216: 11-19, 1948.
27. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-e107, 2008.
28. Kiroycheva M, Ahmed F, Anthony GM, Szabo C, Southan GJ, Bank N. Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol 11: 1026-1032, 2000.
29. Madani G, Papadopoulou AM, Holloway B, Robins A, Davis J, Murray D. The radiological manifestations of sickle cell disease. Clin Radiol 62: 528-538, 2007.
30. Miller WA, Peck D, Lowman RM. Perirenal hematoma in association with renal infarction in sickle-cell trait. Radiology 92: 351-352, 1969.
31. Nagel RL. A knockout of a transgenic mouse - animal models of sickle cell anemia. N Engl J Med 339: 194-195, 1998.
32. Nagel RL, Fabry ME. The panoply of animal models for sickle cell anaemia. Br J Haematol 112: 19-25, 2001.
33. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006.
34. Nath KA, Grande JP, Croatt AJ, Frank E, Caplice NM, Hebbel RP, Katusic ZS. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 166: 963-972, 2005.
35. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, Hebbel RP. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893-903, 2001.
36. Nath KA, Katusic ZS, Gladwin MT. The perfusion paradox and vascular instability in sickle cell disease. Microcirculation 11: 179-193, 2004.
37. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 109: 665-678, 2000.
38. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96: 314-320, 2000.
39. Paladino JD, Hotchkiss JR, Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res 77: 8-12, 2009.
40. Paszty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, Rubin EM. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278: 876-878, 1997.
41. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, Badley AD, Caplice NM, Griffin MD, Nath KA. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int 68: 611-622, 2005.
42. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84: 363-376, 2005.
43. Ryan TM, Ciavatta DJ, Townes TM. Knockout-transgenic mouse model of sickle cell disease. Science 278: 873-876, 1997.
44. Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest 118: 1924-1933, 2008.
45. Scheinman JI. Sickle cell disease and the kidney. Nat Clin Pract Nephrol 5: 78-88, 2009.
46. Sickles EA, Korobkin M. Perirenal hematoma as a complication of renal infarction in sickle-cell trait. A case report. Am J Roentgenol Radium Ther Nucl Med 122: 800-803, 1974.
47. Sklar AH, Perez JC, Harp RJ, Caruana RJ. Acute renal failure in sickle cell anemia. Int J Artif Organs 13: 347-351, 1990.
48. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62: 1539-1549, 2002.
49. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
50. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 170: 1820-1830, 2007.
51. Wong WS, Moss AA, Federle MP, Cochran ST, London SS. Renal infarction: CT diagnosis and correlation between CT findings and etiologies. Radiology 150: 201-205, 1984.
52. Yang CW, Ahn HJ, Jung JY, Kim WY, Li C, Choi BS, Kim HW, Kim YS, Moon IS, Kim J, Bang BK. Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation 75: 20-24, 2003.
53. Zager RA. Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol 17: 3-14, 1997.
54. Zager RA, Johnson AC, Lund S, Hanson S. Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response. Am J Physiol Renal Physiol 291: F546-F556, 2006.